Humana Inc Etf Performance
| HUM Etf | USD 324.83 1.37 0.42% |
The etf retains a Market Volatility (i.e., Beta) of 0.14, which attests to not very significant fluctuations relative to the market. As returns on the market increase, Humana's returns are expected to increase less than the market. However, during the bear market, the loss of holding Humana is expected to be smaller as well.
Risk-Adjusted Performance
0 of 100
Weak | Strong |
Very Weak
Over the last 90 days Humana Inc has generated negative risk-adjusted returns adding no value to investors with long positions. In spite of abnormal performance in the last few months, the Etf's basic indicators remain very healthy which may send shares a bit higher in May 2024. The recent disarray may also be a sign of long period up-swing for the ETF investors. ...more
Forward Dividend Yield 0.0109 | Payout Ratio 0.1362 | Last Split Factor 3:2 | Forward Dividend Rate 3.54 | Dividend Date 2024-04-26 |
| Humana dividend paid on 26th of January 2024 | 01/26/2024 |
1 | Should You Pick Humana Stock After A 25 percent Fall This Year | 03/21/2024 |
2 | Humana stock sinks 13.4 percent good thing we told you to sell it the previous day | 04/03/2024 |
3 | The 3 Most Undervalued Healthcare Stocks to Buy in April 2024 | 04/08/2024 |
4 | Markets stall at the start of Q2 - But this stock keeps rallying regardless | 04/09/2024 |
5 | Centene Wins Medicaid Contract to Better Serve Michigan | 04/11/2024 |
6 | Humana Stock Moves -1.17 percent What You Should Know | 04/12/2024 |
7 | Florida issues Medicaid managed care awards booting out UnitedHealth, CVS and Molina | 04/15/2024 |
8 | UnitedHealths Q1 Medical Cost Update, Prudent Outlook Eases Investor Concerns Goldman Sachs | 04/16/2024 |
9 | Insider Trading | 04/18/2024 |
| Begin Period Cash Flow | 5.1 B |
Humana |
Humana Relative Risk vs. Return Landscape
If you would invest 40,861 in Humana Inc on January 20, 2024 and sell it today you would lose (8,378) from holding Humana Inc or give up 20.5% of portfolio value over 90 days. Humana Inc is generating negative expected returns assuming volatility of 2.5454% on return distribution over 90 days investment horizon. In other words, 22% of etfs are less volatile than Humana, and above 99% of all equities are expected to generate higher returns over the next 90 days. Expected Return |
| Risk |
Humana Market Risk Analysis
Today, many novice investors tend to focus exclusively on investment returns with little concern for Humana's investment risk. Standard deviation is the most common way to measure market volatility of etfs, such as Humana Inc, and traders can use it to determine the average amount a Humana's price has deviated from the expected return over a period of time. It is calculated by determining the expected price for the established period and then subtracting this figure from each price point. The differences are then squared, summed, and averaged to produce the variance.
Sharpe Ratio = -0.1294
| Best Portfolio | Best Equity | |||
| Good Returns | ||||
| Average Returns | ||||
| Small Returns | ||||
| Cash | Small Risk | Average Risk | High Risk | Huge Risk |
| Negative Returns | HUM |
Estimated Market Risk
| 2.55 actual daily | 22 78% of assets are more volatile |
Expected Return
| -0.33 actual daily | 0 Most of other assets have higher returns |
Risk-Adjusted Return
| -0.13 actual daily | 0 Most of other assets perform better |
Based on monthly moving average Humana is not performing at its full potential. However, if added to a well diversified portfolio the total return can be enhanced and market risk can be reduced. You can increase risk-adjusted return of Humana by adding Humana to a well-diversified portfolio.
Humana Fundamentals Growth
Humana Etf prices reflect investors' perceptions of the future prospects and financial health of Humana, and Humana fundamentals are critical determinants of its market performance. Overall, investors pay close attention to revenue and earnings growth, profit margins, and debt levels. These fundamentals can have a significant impact on Humana Etf performance.
| Return On Equity | 0.16 | ||||
| Return On Asset | 0.0634 | ||||
| Profit Margin | 0.02 % | ||||
| Operating Margin | 0 % | ||||
| Current Valuation | 30.53 B | ||||
| Shares Outstanding | 120.55 M | ||||
| Price To Earning | 19.12 X | ||||
| Price To Book | 2.32 X | ||||
| Price To Sales | 0.35 X | ||||
| Revenue | 106.44 B | ||||
| EBITDA | 4.6 B | ||||
| Cash And Equivalents | 5.06 B | ||||
| Cash Per Share | 143.73 X | ||||
| Total Debt | 12.27 B | ||||
| Debt To Equity | 0.85 % | ||||
| Book Value Per Share | 133.05 X | ||||
| Cash Flow From Operations | 3.98 B | ||||
| Earnings Per Share | 20.01 X | ||||
| Total Asset | 46.89 B | ||||
| Retained Earnings | 27.54 B | ||||
| Current Asset | 2.76 B | ||||
| Current Liabilities | 2.39 B | ||||
About Humana Performance
To evaluate Humana Inc Etf as a possible investment, you need to clearly understand its upside potential, downside risk, and overall future performance outlook. You may be satisfied when Humana generates a 15% return over the last few months, but what if the market is generating 25% over the same period? In this case, it makes sense to compare Humana Etf's performance with different market indexes, such as the Dow or NASDAQ Composite. These indexes can act as benchmarks that will help you to understand Humana Inc market performance in a much more refined way. The Macroaxis performance score is an integer between 0 and 100 that represents Humana's market performance from a risk-adjusted return perspective. Generally speaking, the higher the score, the better is overall performance as compared to other investors. The score is normalized against the average investing universe (the best we can interpret from the data available). Within this methodology, scores of individual equity instruments will always be inferior to the scores of portfolios of equities as portfolios typically diversify a lot of unsystematic risks away. The formula to derive the Macroaxis score bases on multiple unequally-weighted factors. For more information, refer to our portfolio performance evaluation section.
Please also refer to our technical analysis and fundamental analysis pages.Humana Inc., together with its subsidiaries, operates as a health and well-being company in the United States. Humana Inc. was founded in 1961 and is headquartered in Louisville, Kentucky. Humana operates under Healthcare Plans classification in the United States and is traded on New York Stock Exchange. It employs 95500 people.| Humana Inc generated a negative expected return over the last 90 days | |
| Over 94.0% of the company shares are owned by institutional investors | |
| Latest headline from benzinga.com: Insider Trading | |
| The fund retains all of the assets under management (AUM) in different types of exotic instruments |
Check out Risk vs Return Analysis to better understand how to build diversified portfolios, which includes a position in Humana Inc. Also, note that the market value of any etf could be tightly coupled with the direction of predictive economic indicators such as signals in employment. You can also try the Idea Breakdown module to analyze constituents of all Macroaxis ideas. Macroaxis investment ideas are predefined, sector-focused investing themes.
The market value of Humana Inc is measured differently than its book value, which is the value of Humana that is recorded on the company's balance sheet. Investors also form their own opinion of Humana's value that differs from its market value or its book value, called intrinsic value, which is Humana's true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because Humana's market value can be influenced by many factors that don't directly affect Humana's underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.
Please note, there is a significant difference between Humana's value and its price as these two are different measures arrived at by different means. Investors typically determine if Humana is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, Humana's price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.